...
首页> 外文期刊>BMC Medical Imaging >Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models
【24h】

Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models

机译:高级胶质瘤和孤零性脑转移的差异:五种扩散加权MRI模型的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To compare the diagnostic performance of neurite orientation dispersion and density imaging (NODDI), mean apparent propagator magnetic resonance imaging (MAP-MRI), diffusion kurtosis imaging (DKI), diffusion tensor imaging (DTI) and diffusion-weighted imaging (DWI) in distinguishing high-grade gliomas (HGGs) from solitary brain metastases (SBMs). Patients with previously untreated, histopathologically confirmed HGGs (n?=?20) or SBMs (n?=?21) appearing as a solitary and contrast-enhancing lesion on structural MRI were prospectively recruited to undergo diffusion-weighted MRI. DWI data were obtained using a q-space Cartesian grid sampling procedure and were processed to generate parametric maps by fitting the NODDI, MAP-MRI, DKI, DTI and DWI models. The diffusion metrics of the contrast-enhancing tumor and peritumoral edema were measured. Differences in the diffusion metrics were compared between HGGs and SBMs, followed by receiver operating characteristic (ROC) analysis and the Hanley and McNeill test to determine their diagnostic performances. NODDI-based isotropic volume fraction (Viso) and orientation dispersion index (ODI); MAP-MRI-based mean-squared displacement (MSD) and q-space inverse variance (QIV); DKI-generated radial, mean diffusivity and fractional anisotropy (RDk, MDk and FAk); and DTI-generated radial, mean diffusivity and fractional anisotropy (RD, MD and FA) of the contrast-enhancing tumor were significantly different between HGGs and SBMs (p??0.05). The best single discriminative parameters of each model were Viso, MSD, RDk and RD for NODDI, MAP-MRI, DKI and DTI, respectively. The AUC of Viso (0.871) was significantly higher than that of MSD (0.736), RDk (0.760) and RD (0.733) (p??0.05). NODDI outperforms MAP-MRI, DKI, DTI and DWI in differentiating between HGGs and SBMs. NODDI-based Viso has the highest performance.
机译:比较神经沸石取向分散和密度成像(Noddi)的诊断性能,平均表观传播磁共振成像(MAP-MRI),扩散峰成像(DKI),扩散张量成像(DTI)和扩散加权成像(DWI)区分高等胶质瘤(HGGS)从孤立脑转移(SBMS)。患者以前未经处理的,组织病理学证实的HGGS(N?=Δ20)或SBMS(N?=β21)出现为在结构MRI上的孤立和对比增强病变,以进行扩散加权MRI。使用Q空间笛卡尔栅格采样程序获得DWI数据,并通过拟合Noddi,Map-MRI,DKI,DTI和DWI模型来处理以生成参数映射。测量了对比增强肿瘤和Peritumoral水肿的扩散度量。在HGGS和SBM之间比较了扩散度量的差异,然后是接收器操作特征(ROC)分析和Hanley和McNeill测试以确定其诊断性能。基于Noddi的各向同性体积分数(VISO)和取向分散指数(ODI);地图-MRI为基于平均平方位移(MSD)和Q空间逆差(QIV); DKI产生的径向,平均扩散性和分数各向异性(RDK,MDK和FAK);和DTI产生径向的,平均扩散率和分数各向异性的对比度增强肿瘤的(RD,MD和FA)是HGGs和SBM的(P <??0.05)之间显著不同。每个模型的最佳单判别参数为维索,MSD,RDK和RD为NODDI,MAP-MRI,DKI和DTI,分别。 VISO(0.871)的AUC显着高于MSD(0.736),RDK(0.760)和RD(0.733)(P?<β05)。 Noddi优于Map-MRI,DKI,DTI和DWI在区分HGGS和SBMS之间。基于Noddi的viso具有最高的性能。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号